Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Contract Research Organization providing Phase I-IV core development 
services for drug, biologic, and device programs
News and Upcoming Events
GENERAL CAPABILITIES


VIEW NOW more
request info
First Name*:
Last Name*:
Company*:
Email*:
Leave a Message:


Please enter the security code


Find out how our medical, regulatory, and operational expertise in clinical development can help with your next study or program.


News Releases

2014

Medpace expands therapeutic leadership in Oncology with the addition of Franklin O. Smith, III, MD, as Vice President, Medical Affairs

Medpace expands offices in the UK, supporting rapid growth in European Clinical Teams

David Klein, MD, PhD joins Medpace as a Medical Director, Further Strengthening Global Endocrinology and Pediatric Drug Development Capabilities

Medpace Quality Assurance Executive Joins Industry Experts to conduct DIA Training in Beijing

Medpace Reference Laboratories (MRL) opens central laboratory in Singapore

Medpace Strengthens Cardiovascular, Pediatric, and Rare Disease Drug and Medical Device Development Capabilities: Dr. Pirouz Shamszad MD, FAAP joins Medpace as a Medical Director

NephroGenex picks Medpace for kidney disease Phase III

Medpace to Present at Partnerships in Clinical Trials 2014: Argos Therapeutics and Medpace present lessons learned from an oncology rescue study

Cinven invests in Medpace, citing strong growth drivers in the CRO market

Medpace to Present at Outsourcing Clinical Trials – West Coast

Medpace Strengthens Global Oncology Drug Development Capabilities - Dr. Jamal Gasmi joins Medpace as Medical Director

Cardiac Safety Research Consortium (CSRC) Releases Cardiovascular Case Report Forms for use in Non Cardiovascular Clinical Trials

2013

MediTech Strategic Consultants B.V. changes name to Medpace Medical Device B.V.

Medpace recognized as a member of the Deloitte Cincinnati USA 100 for the 6th consecutive year

Medpace publishes new white paper: The Role of the CRO in Effective Risk-Based Monitoring

Medpace to participate in panel discussion on “Overcoming Regulatory Hurdles to Regenerative Medicine” at Alliance for Regenerative Medicine’s Stem Cell Meeting on the Mesa

The Medpace Bioanalytical Laboratories Team presents Scientific Posters at 61st ASMS Conference on Mass Spectrometry Bioanalytical Laboratories team presents scientific posters at ASMS Conference

Subject Recruitment: Are You Prepared to Succeed? Peer Reviewed Article Published in Association of Clinical Research Professionals (ACRP) publication

Lessons Learned from the Use of Central Endoscopy Review in Inflammatory Bowel Disease Trials: Medpace Physicians Author Article that Summarizes Recent Developments

Dr. Alex Mescheder Joins Medpace as Vice President Medical and Regulatory Affairs, Europe - Medpace Continues its Aggressive European Expansion

2012

Medpace, Inc. acquires MediTech Strategic Consultants B.V., a European-based Contract Research Organization (CRO) Specializing in Medical Device

Medpace completes relocation of Medpace Reference Laboratories (MRL), doubling Medpace central laboratory capacity

Medpace completes construction on a new Clinical Pharmacology Unit - expanding Phase I-IIa clinical research capabilities

Medpace, Inc. hits 20 year mark as a full service, global CRO

"First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites" by Marc Salzberg, MD

Medpace announces the addition of Cheri Lindberg, MD, Medical Director, strengthening Medpace’s Therapeutic and Regulatory Expertise in Psychiatry

Medpace CEO and Founder, August J. Troendle, MD, accepts the Lifetime Achievement Award for Innovation from the Cincinnati USA Regional Chamber

Medpace welcomes Piotr Krzeski, MD, PhD, MFPM, Medical Director adding expertise in Gastroenterology

Medpace opens office in Lyon, France

Medpace announces the addition of Jason D. Hurt, MD, Medical Director, strengthening Medpace Therapeutic Expertise in Gynecologic Oncology